Characterization of a psoriatic skin model produced with involved or uninvolved cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 7, 2015, Pages 789-798

  Jean, Jessica ^a,b   Leroy, Marie ^a,b   Duque Fernandez, Alexandra ^a,b   Bernard, Geneviève ^a   Soucy, Jacques ^c   Pouliot, Roxane ^a,b  

^a Centre de recherche FRSQ du CHA universitaire de Québec   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

in vitro models; Lipid organization; Permeability; Psoriasis; Skin substitutes

Indexed keywords

SELF ASSEMBLY;

'CURRENT; CELL DIFFERENTIATION; IN-VITRO MODELS; LIPID ORGANIZATION; PERMEABILITY; PSORIATIC PLAQUES; SKIN MODEL; SKIN SUBSTITUTES; STRATUM CORNEUM; TRIGGERING FACTORS;

CELL PROLIFERATION;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN FIBROBLAST; STRATUM CORNEUM; TISSUE ENGINEERING; ARTIFICIAL SKIN; BIOLOGICAL MODEL; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS;

ADULT; AGED; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PSORIASIS; SKIN, ARTIFICIAL;

EID: 84957840295     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1666     Document Type: Article

References (47)

1. Alessandrini F, Stachowitz S, Ring J, Behrendt H. 2001; The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 116: 394-400.
2. Auger FA, Lopez Valle CA, Guignard R, et al. 1995; Skin equivalent produced with human collagen. In Vitro Cell Dev Biol Anim 31: 432-439.
3. Barker CL, McHale MT, Gillies AK, et al. 2004; The development and characterization of an in vitro model of psoriasis. J Invest Dermatol 123: 892-901.
4. Barker JN, Mitra RS, Griffiths CE, et al. 1991; Keratinocytes as initiators of inflammation. Lancet 337: 211-214.
5. Bowcock AM. 2005; The genetics of psoriasis and autoimmunity. Annu Rev Genom Hum Genet 6: 93-122.
6. Boyman O, Hefti HP, Conrad C, et al. 2004; Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J Exp Med 199: 731-736.
7. Chen G, McCormick TS, Hammerberg C, et al. 2001; Basal keratinocytes from uninvolved psoriatic skin exhibit accelerated spreading and focal adhesion kinase responsiveness to fibronectin. J Invest Dermatol 117: 1538-1545.
8. Conrad C, Boyman O, Tonel G, et al. 2007; α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 13: 836-842.
9. Farwanah H, Raith K, Neubert RH, et al. 2005; Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res 296: 514-521.
10. Franz TJ. 1975; Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 64: 190-195.
11. Germain L, Auger FA. 1995; Tissue engineered biomaterials: biological and mechanical characteristics. In Encyclopedic Handbook of Biomaterials and Bioengineering, Wise DL, Altobelli DA, Yaszemski MJ, et al. (eds). Marcel Dekker: New York; 699-734.
12. Germain L, Rouabhia M, Guignard R, et al. 1993; Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19: 99-104.
13. Goodwin P, Hamilton S, Fry L. 1973; A comparison between DNA synthesis and mitosis in uninvolved and involved psoriatic epidermis and normal epidermis. Br J Dermatol 89: 613-618.
14. Grabe N, Neuber K. 2007; Simulating psoriasis by altering transit amplifying cells. Bioinformatics 23: 1309-1312.
15. Harper RA, Rispler J, Urbanek RW. 1978; DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro. J Invest Dermatol 70: 254-256.
16. Jean J, Lapointe M, Soucy J, et al. 2009; Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci 53: 19-25.
17. Kamili QU, Menter A. 2009; Topical treatment of psoriasis. Curr Probl Dermatol 38: 37-58.
18. King CS, Nicholls S, Barton S, et al. 1979; Is the stratum corneum of uninvolved psoriatic skin abnormal? Acta Derm Venereol Suppl (Stockh) 59: 95-100.
19. Kormeili T, Lowe NJ, Yamauchi PS. 2004; Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; US experiences. Br J Dermatol 151: 3-15.
20. Krueger GG, Chambers DA, Shelby J. 1981; Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. J Clin Invest 68: 1548-1557.
21. Krueger JG, Bowcock A. 2005; Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(suppl 2): ii30-36.
22. Labbe B, Marceau-Fortier G, Fradette J. 2011; Cell sheet technology for tissue engineering: the self-assembly approach using adipose-derived stromal cells. Methods Mol Biol 702: 429-441.
23. Larouche D, Lavoie A, Proulx S, et al. 2009a; [Regenerative medicine: stem cells, cellular and matricial interactions in the reconstruction of skin and cornea by tissue engineering]. Pathol Biol (Paris) 57: 299-308.
24. Larouche D, Paquet C, Fradette J, et al. 2009b; Regeneration of skin and cornea by tissue engineering. Methods Mol Biol 482: 233-256.
25. Lima XT, Abuabara K, Kimball AB, et al. 2009; Briakinumab. Expert Opin Biol Ther 9: 1107-1113.
26. Lowes MA, Bowcock AM, Krueger JG. 2007; Pathogenesis and therapy of psoriasis. Nature 445: 866-873.
27. Menter A, Stoff B. 2010; Psoriasis. Manson Publishing: London.
28. Michel M, L'Heureux N, Auger FA, et al. 1997; From newborn to adult: phenotypic and functional properties of skin equivalent and human skin as a function of donor age. J Cell Physiol 171: 179-189.
29. Michel M, L'Heureux N, Pouliot R, et al. 1999; Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 35: 318-326.
30. Nickoloff BJ. 2006; Keratinocytes regain momentum as instigators of cutaneous inflammation. Trends Mol Med 12: 102-106.
31. Paquet C, Larouche D, Bisson F, et al. 2010; Tissue engineering of skin and cornea: development of new models for in vitro studies. Ann NY Acad Sci 1197: 166-177.
32. Pershing LK, Bakhtian S, Wright ED. 1995; Differentiation of involved and uninvolved psoriatic skin from healthy skin using noninvasive visual, colorimeter and evaporimeter method. Skin Res Technol 1: 140-144.
33. Proulx S, Fradette J, Gauvin R, et al. 2010; Stem cells of the skin and cornea: their clinical applications in regenerative medicine. Curr Opin Organ Transpl 16(1): 87-89.
34. Ragaz A, Ackerman AB. 1979; Evolution, maturation, and regression of lesions of psoriasis. New observations and correlation of clinical and histologic findings. Am J Dermatopathol 1: 199-214.
35. Raychaudhuri SP, Dutt S, Raychaudhuri SK, et al. 2001; Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation. Br J Dermatol 144: 931-939.
36. Rochon MH, Fradette J, Fortin V, et al. 2010; Normal human epithelial cells regulate the size and morphology of tissue-engineered capillaries. Tissue Eng Part A 16: 1457-1468.
37. Schon MP, Boehncke WH. 2005; Psoriasis. N Engl J Med 352: 1899-1912.
38. Sullivan-Whalen M, Gilleaudeau P. 2007; Psoriasis: hope for the future. Nurs Clin North Am 42: 467-84, vii.
39. Ting KM, Rothaupt D, McCormick TS, et al. 2000; Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin. J Invest Dermatol 114: 706-711.
40. Trottier V, Marceau-Fortier G, Germain L, et al. 2008; IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells 26: 2713-2723.
41. Tzu J, Krulig E, Cardenas V, et al. 2008; Biological agents in the treatment of psoriasis. G Ital Dermatol Venereol 143: 315-327.
42. Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, et al. 2009; Psoriasis - as an autoimmune disease caused by molecular mimicry. Trends Immunol 30: 494-501.
43. Vallee M, Cote JF, Fradette J. 2009; Adipose-tissue engineering: taking advantage of the properties of human adipose-derived stem/stromal cells. Pathol Biol (Paris) 57: 309-317.
44. van de Kerkhof PC, Rulo HF, van Pelt JP, et al. 1998; Expression of endoglin in the transition between psoriatic uninvolved and involved skin. Acta Derm Venereol 78: 19-21.
45. Vermette M, Trottier V, Menard V, et al. 2007; Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells. Biomaterials 28: 2850-2860.
46. Weinstein GD, Frost P. 1968; Abnormal cell proliferation in psoriasis. J Invest Dermatol 50: 254-259.
47. Zenz R, Eferl R, Kenner L, et al. 2005; Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437: 369-375.